Benutzer: Gast  Login
Dokumenttyp:
Meeting Abstract
Autor(en):
Litton, Jennifer K.; Hurvitz, Sara A.; Mina, Lida A.; Rugo, Hope S.; Lee, Kyung-Hun; Goncalves, Anthony; Diab, Sami; Woodward, Natasha; Goodwin, Annabel; Yerushalmi, Rinat; Roch, Henri; Im, Young-Hyuck; Eiermann, Wolfgang; Quek, Ruben G.; Usari, Tiziana; Lanzalone, Silvana; Czibere, Akos; Blum, Joanne L.; Martin, Miguel; Ettl, Johannes
Titel:
Talazoparib (TALA) in germline BRCA1/2 (gBRCA1/2)-mutated human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer (ABC): Final overall survival (OS) results from randomized Phase 3 EMBRACA trial
Zeitschriftentitel:
Cancer Res
Jahr:
2020
Band / Volume:
80 Suppl S
Heft / Issue:
16
Volltext / DOI:
doi:10.1158/1538-7445.AM2020-CT071
Print-ISSN:
0008-5472
TUM Einrichtung:
Frauenklinik und Poliklinik
 BibTeX